UCB0107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB0107, covering 2025-07-29 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy [Phase 1]